eflapegrastim
Generic: eflapegrastim·Brand: Rolvedon
eflapegrastim: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SPECTRUM PHARMACEUTICALS INC (SPPI) | Phase 2 |
Clinical Trials (1)
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Frequently asked questions
Who is developing eflapegrastim?
eflapegrastim is being developed by SPECTRUM PHARMACEUTICALS INC.
How many clinical trials involve eflapegrastim?
BioSniper tracks 1 clinical trial involving eflapegrastim.
Get deeper analysis on eflapegrastim
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis